논문 페이지 | PnH

최근소식

회사소개 사업소개 치료기술 암종별치료 최근소식 고객센터

논문 치료사례 동영상게시판 사진게시판

논문

번호 제목 날짜

385

2025년 Science Translation Medicine : OX40-heparan sulfate binding facilitates CAR-T cell penetration into solid tumors in mice

2025년 Science Translation Medicine : OX40-heparan sulfate binding facilitates CAR-T cell penetration into solid tumors in mice
2025-07-08
384

2025년 ournal for ImmunoTherapy of Cancer:Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells

2025년 ournal for ImmunoTherapy of Cancer:Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells
2025-07-08
383

2025년 Nature: CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells (2)

2025년 Nature: CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells (2)
2025-07-08
382

2025년 Nature: CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

2025년 Nature: CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
2025-07-08
381

2025년 Science:In vivo CAR T cell generation to treat cancer and autoimmune disease

2025년 Science:In vivo CAR T cell generation to treat cancer and autoimmune disease
2025-07-08
380

2025년 Cell Stem Cell:Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy

2025년 Cell Stem Cell:Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
2025-06-25
379

2025년 CLDN18.2 위암 CAR-T타겟 연구 결과 발표

2025년 CLDN18.2 위암 CAR-T타겟 연구 결과 발표
2025-06-25
378

2025년 Nature Medicine: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial

2025년 Nature Medicine: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
2025-06-17
377

2025년 Cell Med: Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy

2025년 Cell Med: Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy
2025-06-17
376

2025년 Nature Cancer: Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure

2025년 Nature Cancer: Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure
2025-06-17